Clinical Trial: A Prospective, Multicenter, Single-Arm, Open-Label, Non-Randomized Exploratory Study to Evaluate the Efficacy and Safety of an Ultrasound Stimulation Device (NEFRONIX) for Improving Glomerular Filtration Rate (CKD-EPI eGFR) in Patients With Chronic Kidney Disease

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339098) titled 'A Prospective, Multicenter, Single-Arm, Open-Label, Non-Randomized Exploratory Study to Evaluate the Efficacy and Safety of an Ultrasound Stimulation Device (NEFRONIX) for Improving Glomerular Filtration Rate (CKD-EPI eGFR) in Patients With Chronic Kidney Disease' on Jan. 05.

Brief Summary: This study is a prospective, multicenter, single-arm, open-label, non-randomized exploratory clinical trial designed to evaluate the safety and potential efficacy of an ultrasound stimulation device (NEFRONIX G-01) in patients with chronic kidney disease (CKD). Baseline functional assessments will be performed prior to intervention. Participants ...